Equillium Inc (NASDAQ: EQ) closed the day trading at $2.06 down -15.57% from the previous closing price of $2.44. In other words, the price has decreased by -$0.3800 from its previous closing price. On the day, 693498 shares were traded.
Ratios:
For a better understanding of EQ, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.79 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On September 15, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $14.
H.C. Wainwright reiterated its Buy rating for the stock on July 14, 2020, while the target price for the stock was revised from $14 to $24.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EQ now has a Market Capitalization of 69.89M and an Enterprise Value of 24.51M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.25 while its Price-to-Book (P/B) ratio in mrq is 3.22. Its current Enterprise Value per Revenue stands at 0.57 whereas that against EBITDA is -3.62.
Stock Price History:
Over the past 52 weeks, EQ has reached a high of $3.25, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 1.8868, while the 200-Day Moving Average is calculated to be 1.0032.
Shares Statistics:
Over the past 3-months, EQ traded about 353.80K shares per day on average, while over the past 10 days, EQ traded about 263.87k shares per day. A total of 35.25M shares are outstanding, with a floating share count of 3.92M. Insiders hold about 82.17% of the company’s shares, while institutions hold 12.03% stake in the company. Shares short for EQ as of Feb 29, 2024 were 367.06k with a Short Ratio of 1.04, compared to 519.68k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.05% and a Short% of Float of 1.68%.
Earnings Estimates
Current recommendations for the stock of the company come from 0 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.02. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
Revenue Estimates
1 analysts predict $8M in revenue for the current quarter. It ranges from a high estimate of $8M to a low estimate of $8M. As of the current estimate, Equillium Inc’s year-ago sales were $2.91M, an estimated increase of 174.50% from the year-ago figure.
A total of 1 analysts have provided revenue estimates for EQ’s current fiscal year. The highest revenue estimate was $34M, while the lowest revenue estimate was $34M, resulting in an average revenue estimate of $34M. In the same quarter a year ago, actual revenue was $10.98M, up 209.70% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $24M in the next fiscal year. The high estimate is $24M and the low estimate is $24M. The average revenue growth estimate for next year is down -29.40% from the average revenue estimate for this year.
